HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer
ACS Applied Materials & Interfaces · 22.05.2024 · 16 (20) · 25710-25726
DOI: 10.1021/acsami.4c02532 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 13.05.2024. Verfasst von Archana M G und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (RCC), Thiruvananthapuram 695011, Kerala, Indi…. Hauptthemen laut MEDLINE: Breast Neoplasms, Doxorubicin, Gene Silencing, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (RCC), Thiruvananthapuram 695011, Kerala, India.
- Centre for Nanotechnology, Indian Institute of Technology (IIT), Roorkee 247667, Uttarakhand, India.
- Chemical Sciences & Technology Division (CSTD), Organic Chemistry Section, CSIR-National Institute for Interdisciplinary Science & Technology (CSIR-NIIST), Thiruvananthapuram 695019, Kerala, India.
- Department of Life Sciences, CHRIST University, Banglore 560029, India.
ORCID-Profile: Sreekutty J, Manu M Joseph, Sreelekha T T
Förderung
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
Zitieren
APA
M G, A., K S, A., B S, U., P L, R., H P, S., J, S., Joseph, M. M., & T T, S. (2024). HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer. ACS Applied Materials & Interfaces, 16(20), 25710-25726. https://doi.org/10.1021/acsami.4c02532
Vancouver
M G A, K S A, B S U, P L R, H P S, J S, et al. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer. ACS Applied Materials & Interfaces. 2024;16(20):25710-25726. doi:10.1021/acsami.4c02532
BibTeX
@article{MG2024,
author = {M G, Archana and K S, Anusree and B S, Unnikrishnan and P L, Reshma and H P, Syama and J, Sreekutty and Joseph, Manu M and T T, Sreelekha},
title = {HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {20},
pages = {25710--25726},
doi = {10.1021/acsami.4c02532}
}
EUVIMED